| 标题 |
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial |
| 网址 | |
| DOI | |
| 其它 | PMID:35857827 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)